1. Erm Jauniaux, Z Alfirevic, A G Bhide, M A Belfort, G J Burton, S L Collins, S Dornan, D Jurkovic, G Kayem, J Kingdom, R Silver L.S. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a // BJOG An Int. J. Obstet. Gynaecol. 2018.

2. Jauniaux E. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management // BJOG An Int. J. Obstet. Gynaecol. 2019. Vol. 126, N 1. P. e1 - e48.

3. Guideline No. 402 Diagnosis ana Management of Placenta Previa. J Obstet GynaecolCan. 2020.

4. De Mucio B. et al. A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta // Int. J. Gynecol. Obstet. 2019. Vol. 147, N 3. P. 281 - 291.

5. Chen Y. et al. Persistent hypoxia induced autophagy leading to invasiveness of trophoblasts in placenta accreta. // J. Matern. Fetal. Neonatal Med. 2021. Vol. 34, N 8. P. 1297 - 1303.

6. Timor-Tritsch I.E. et al. Cesarean scar pregnancy and early placenta accreta share common histology. // Ultrasound Obstet. Gynecol. 2014. Vol. 43, N 4. P. 383 - 395.

7. Society of Gynecologic Oncology et al. Placenta Accreta Spectrum. // Am. J. Obstet. Gynecol. 2018. Vol. 219, N 6. P. B2 - B16.

8. Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. // Am. J. Obstet. Gynecol. 2017. Vol. 217, N 1. P. 27 - 36.

9. Morlando M. et al. Reproductive outcome after cesarean scar pregnancy: A systematic review and meta-analysis. // Acta Obstet. Gynecol. Scand. 2020. Vol. 99, N 10. P. 1278 - 1289.

10. Jauniaux E. et al. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. // BMJ Open. 2019. Vol. 9, N 11. P. e031193.

11. Martimucci K. et al. Interpregnancy interval and abnormally invasive placentation. // Acta Obstet. Gynecol. Scand. 2019. Vol. 98, N 2. P. 183 - 187.

12. Castaneda S., Karrison T., Cibils L.A. Peripartum hysterectomy. // J. Perinat. Med. 2000. Vol. 28, N 6. P. 472 - 481.

13. Iacovelli A. et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, N 3. P. 471 - 481.

14. Fitzpatrick K.E. et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. // PLoS One. 2012. Vol. 7, N 12. P. e52893.

15. Cali G. et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and metaanalysis // Ultrasound Obstet. Gynecol. 2018. Vol. 51, N 2. P. 169 - 175.

16. Kohn J.R. et al. Pregnancy after endometrial ablation: a systematic review. // BJOG. 2018. Vol. 125, N 1. P. 43 - 53.

17. Marshall N.E., Fu R., Guise J.-M. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. // Am. J. Obstet. Gynecol. 2011. Vol. 205, N 3. P. 262. e1 - 8.

18. Weis M.A. et al. Natural history of placenta previa in twins. // Obstet. Gynecol. 2012. Vol. 120, N 4. P. 753 - 758.

19. Read J.A., Cotton D.B., Miller F.C. Placenta accreta: changing clinical aspects and outcome. // Obstet. Gynecol. 1980. Vol. 56, N 1. P. 31 - 34.

20. Wu S., Kocherginsky M., Hibbard J.U. Abnormal placentation: twenty-year analysis. // Am. J. Obstet. Gynecol. 2005. Vol. 192, N 5. P. 1458 - 1461.

21. Amin M.B. et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. // CA. Cancer J. Clin. 2017. Vol. 67, N 2. P. 93 - 99.

22. Reddy U.M. et al. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecolog // J. Ultrasound Med. 2014. Vol. 33, N 5. P. 745 - 757.

23. Jauniaux E. et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. // Int. J. Gynaecol. Obstet. 2019. Vol. 146, N 1. P. 20 - 24.

24. Palacios-Jaraquemada J.M. et al. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, N 19. P. 3377 - 3384.

25. Expert Panel on Women's Imaging et al. ACR Appropriateness Criteria Placenta Accreta Spectrum Disorder. // J. Am. Coll. Radiol. 2020. Vol. 17, N 5S. P. S207 - S214.

26. Савельева Г.М., Курцер М.А., Бреслав И.Ю., Панина О.Б., Андреев А.И., Барыкина О.П. Л.О.А. Врастание предлежащей плаценты (placenta accreta) у пациенток с рубцом на матке после кесарева сечения. Клинико-морфологическое сопоставление // Акушерство и Гинекология. 2015.

27. Jain V., Bos H., Bujold E. Guideline No. 402: Diagnosis and Management of Placenta Previa // J. Obstet. Gynaecol. Canada. 2020. Vol. 42, N 7. P. 906 - 917.e1.

28. Zhou L.M. et al. Relation of hemoglobin measured at different times in pregnancy to preterm birth and low birth weight in Shanghai, China. // Am. J. Epidemiol. 1998. Vol. 148, N 10. P. 998 - 1006.

29. Steer P., Alam M.A., Wadsworth J. W.A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. // BMJ. 1995. P. 310(6978): 489 - 91.

30. Abide Yayla C. et al. Predictive value of complete blood count parameters for placental invasion anomalies // J. Matern. Neonatal Med. 2017. Vol. 30, N 19. P. 2324 - 2328.

31. Guidelines for blood grouping and red cell antibody testing during pregnancy. British Committee for Standards in Haematology, Blood Transfusion Task Force. // Transfus. Med. 1996. Vol. 6, N 1. P. 71 - 74.

32. UK Blood Transfusion Services. Guidelines for the Blood Transfusion Service. 8th ed. London: TSO; 2013.

33. Walker G.J. Antibiotics for syphilis diagnosed during pregnancy. // Cochrane database Syst. Rev. 2001. N 3. P. CD001143.

34. Watson-Jones D. et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. // J. Infect. Dis. 2002. Vol. 186, N 7. P. 948 - 957.

35. Volmink J. et al. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. // Cochrane database Syst. Rev. 2007. N 1. P. CD003510.

36. Hobson S.R. et al. No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders // J. Obstet. Gynaecol. Canada. 2019. Vol. 41, N 7. P. 1035 - 1049.

37. Wong V.C. et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. // Lancet (London, England). 1984. Vol. 1, N 8383. P. 921 - 926.

38. Xu Z.Y. et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. // Pediatrics. 1985. Vol. 76, N 5. P. 713 - 718.

39. Hobson S.R. et al. No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders. // J. Obstet. Gynaecol. Can. 2019. Vol. 41, N 7. P. 1035 - 1049.

40. Smaill F.M. Intrapartum antibiotics for Group B streptococcal colonisation // The Cochrane Database of Systematic Reviews / ed. Smaill F.M. Chichester, UK: John Wiley & Sons, Ltd, 1996.

41. Benitz W.E., Gould J.B., Druzin M.L. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. // Pediatrics. 1999. Vol. 103, N 6. P. e78.

42. Prevention of Early-onset Neonatal Group B Streptococcal Disease // BJOG An Int. J. Obstet. Gynaecol. 2017. Vol. 124, N 12. P. e280 - e305.

43. D'Antonio F. et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 51, N 2. P. 176 - 183.

44. Panaiotova J. et al. Screening for morbidly adherent placenta in early pregnancy. // Ultrasound Obstet. Gynecol. 2019. Vol. 53, N 1. P. 101 - 106.

45. Melcer Y. et al. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. // Am. J. Obstet. Gynecol. 2018. Vol. 218, N 4. P. 443.e1 - 443.e8.

46. Stafford I.A. et al. Ultrasonographic cervical length and risk of hemorrhage in pregnancies with placenta previa. // Obstet. Gynecol. 2010. Vol. 116, N 3. P. 595 - 600.

47. Zaitoun M.M. et al. Does cervical length and the lower placental edge thickness measurement correlates with clinical outcome in cases of complete placenta previa? // Arch. Gynecol. Obstet. 2011. Vol. 284, N 4. P. 867 - 873.

48. Buca D. et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 52, N 3. P. 304 - 309.

49. Jauniaux E. et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. // Int. J. Gynaecol. Obstet. 2018. Vol. 140, N 3. P. 274 - 280.

50. D'Antonio F., Iacovella C., Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2013. Vol. 42, N 5. P. 509 - 517.

51. Collins S.L. et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). // Ultrasound Obstet. Gynecol. 2016. Vol. 47, N 3. P. 271 - 275.

52. Alfirevic Z. et al. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. // Ultrasound Obstet. Gynecol. 2016. Vol. 47, N 3. P. 276 - 278.

53. D'Antonio F. et al. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2014. Vol. 44, N 1. P. 8 - 16.

54. Neilson J.P. Interventions for suspected placenta praevia. // Cochrane database Syst. Rev. 2003. N 2. P. CD001998.

55. Familiari A. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. // Acta Obstet. Gynecol. Scand. 2018. Vol. 97, N 5. P. 507 - 520.

56. Poder L. et al. ACR Appropriateness Criteria Placenta Accreta Spectrum Disorder // J. Am. Coll. Radiol. 2020. Vol. 17, N 5. P. S207 - S214.

57. Obstetric Care Consensus No. 7 Summary: Placenta Accreta Spectrum // Obstet. Gynecol. 2018. Vol. 132, N 6. P. 1519 - 1521.

58. Obstetric care consensus // Am. Coll. Obstet. Gynecol. 2012. Vol. 529. P. 259 - 275.

59. Jha P. et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. // Eur. Radiol. 2020. Vol. 30, N 5. P. 2604 - 2615.

60. Hecht J.L. et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. // Mod. Pathol. 2020. Vol. 33, N 12. P. 2382 - 2396.

61. Wing D.A., Paul R.H., Millar L.K. Management of the symptomatic placenta previa: a randomized, controlled trial of inpatient versus outpatient expectant management. // Am. J. Obstet. Gynecol. 1996. Vol. 175, N 4 Pt 1. P. 806 - 811.

62. Pivano A. et al. A score to predict the risk of emergency caesarean delivery in women with antepartum bleeding and placenta praevia. // Eur. J. Obstet. Gynecol. Reprod. Biol. 2015. Vol. 195. P. 173 - 176.

63. Ruiter L. et al. Predictors for Emergency Cesarean Delivery in Women with Placenta Previa. // Am. J. Perinatol. 2016. Vol. 33, N 14. P. 1407 - 1414.

64. Балашова Е.Н., Ионов О.В., Киртбая А.Р., Никонец А.Д., Михеева А.А., Васильченко О.Н., Зубков В.В., Шмаков Р.Г. Д.Д.Н. Особенности дыхательных и сердечно-сосудистых нарушений у недоношенных детей, рожденных у матерей с врастанием плаценты // Акушерство и гинекология. 2021.

65. Silver R.M. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. // Obstet. Gynecol. 2015. Vol. 126, N 3. P. 654 - 668.

66. Jauniaux E. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. // BJOG. 2019. Vol. 126, N 1. P. e1 - e48.

67. Seif K.E. et al. Neonatal Outcomes in Pregnancies Complicated by Placenta Accreta Spectrum // Am. J. Obstet. Gynecol. 2022. Vol. 226, N 1. P. S749 - S750.

68. Ahn K.H. et al. Anterior placenta previa in the mid-trimester of pregnancy as a risk factor for neonatal respiratory distress syndrome // PLoS One / ed. Mastrolia S.A. 2018. Vol. 13, N 11. P. e0207061.

69. Tsuda H. et al. Effect of placenta previa on neonatal respiratory disorders and amniotic lamellar body counts at 36 - 38 weeks of gestation // Early Hum. Dev. 2014. Vol. 90, N 1. P. 51 - 54.

70. Stafford I.A. et al. Cervical Pessary versus Expectant Management for the Prevention of Delivery Prior to 36 Weeks in Women with Placenta Previa: A Randomized Controlled Trial. // AJP Rep. 2019. Vol. 9, N 2. P. e160 - e166.

71. Barinov S. V et al. The role of cervical pessary and progesterone therapy in the phenomenon of placenta previa migration. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, N 6. P. 913 - 919.

72. Abbas F. et al. Placenta percreta with bladder invasion as a cause of life threatening hemorrhage. // J. Urol. 2000. Vol. 164, N 4. P. 1270 - 1274.

73. Washecka R., Behling A. Urologic complications of placenta percreta invading the urinary bladder: a case report and review of the literature. // Hawaii Med. J. 2002. Vol. 61, N 4. P. 66 - 69.

74. Виницкий А.А., Шмаков Р.Г. Б.В.Г. Современные методы инструментальной диагностики врастания плаценты // Акушерство и гинекология. 2017.

75. Collins S.L. et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. // Am. J. Obstet. Gynecol. 2019. Vol. 220, N 6. P. 511 - 526.

76. Eller A.G. et al. Optimal management strategies for placenta accreta. // BJOG. 2009. Vol. 116, N 5. P. 648 - 654.

77. РОАГ. Клинические рекомендации "Послеродовое кровотечение". 2021.

78. Клинические рекомендации "Роды одноплодные, родоразрешение путем кесарева сечения". 2021.

79. Taylor N.J., Russell R. Anaesthesia for abnormally invasive placenta: a single-institution case series. // Int. J. Obstet. Anesth. 2017. Vol. 30. P. 10 - 15.

80. Курцер М.А. et al. Врастание плаценты // Акушерство и гинекология. 2002. Vol. 99, N 1. P. 169 - 170.

81. Nguyen-Lu N. et al. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases. // Can. J. Anaesth. 2016. Vol. 63, N 11. P. 1233 - 1244.

82. Khokhar R. et al. Placenta accreta and anesthesia: A multidisciplinary approach // Saudi J. Anaesth. 2016. Vol. 10, N 3. P. 332.

83. Kocaoglu N. et al. Management of anesthesia for cesarean section in parturients with placenta previa with/without placenta accreta: a retrospective study. // Ginekol. Pol. 2012. Vol. 83, N 2. P. 99 - 103.

84. Nguyen-Lu N. et al. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases // Can. J. Anesth. Can. d'anesthesie. 2016. Vol. 63, N 11. P. 1233 - 1244.

85. Markley J.C. et al. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis. // Anesth. Analg. 2018. Vol. 127, N 4. P. 930 - 938.

86. Schmidt G.A. et al. Liberation From Mechanical Ventilation in Critically Ill Adults: Executive Summary of an Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline // Chest. 2017. Vol. 151, N 1. P. 160 - 165.

87. Aoki M. et al. Primary postpartum hemorrhage: outcome of uterine artery embolization // Br. J. Radiol. 2018. P. 20180132.

88. Fyodorova T.A. et al. Massive Hemorrhages in Pregnant Women with Placenta Previa and Accreta: a Transfusiologist's View // Russ. Sklifosovsky J. "Emergency Med. Care." 2018. Vol. 7, N 3. P. 253 - 259.

89. Munoz M. et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. // Blood Transfus. 2019. Vol. 17, N 2. P. 112 - 136.

90. Spruit M.A. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. // Am. J. Respir. Crit. Care Med. 2013. Vol. 188, N 8. P. e13 - 64.

91. Munoz M. et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. // Transfus. Med. 2018. Vol. 28, N 1. P. 22 - 39.

92. Becuzzi N., Zimmermann R., Krafft A. Long-term efficacy of postpartum intravenous iron therapy. // Biomed Res. Int. 2014. Vol. 2014. P. 815437.

93. Munoz M. et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. // Anaesthesia. 2017. Vol. 72, N 2. P. 233 - 247.

94. Smulian J.C. et al. Invasive placental disease: the impact of a multi-disciplinary team approach to management. // J. Matern. Fetal. Neonatal Med. 2017. Vol. 30, N 12. P. 1423 - 1427.

95. Al-Khan A. et al. Maternal and Fetal Outcomes in Placenta Accreta After Institution of Team-Managed Care // Reprod. Sci. 2014. Vol. 21, N 6. P. 761 - 771.

96. Eller A.G. et al. Maternal Morbidity in Cases of Placenta Accreta Managed by a Multidisciplinary Care Team Compared With Standard Obstetric Care // Obstet. Gynecol. 2011. Vol. 117, N 2. P. 331 - 337.

97. Shamshirsaz A.A. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. // Am. J. Obstet. Gynecol. 2015. Vol. 212, N 2. P. 218.e1 - 9.

98. Silver R.M. et al. Center of excellence for placenta accreta. // Am. J. Obstet. Gynecol. 2015. Vol. 212, N 5. P. 561 - 568.

99. Shamshirsaz A.A. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach // Am. J. Obstet. Gynecol. 2015. Vol. 212, N 2. P. 218.e1 - 218.e9.

100. Publications Committee S. for M.-F.M., Belfort M.A. Placenta accreta. // Am. J. Obstet. Gynecol. 2010. Vol. 203, N 5. P. 430 - 439.

101. Rac M.W.F. et al. Placenta accreta and vaginal bleeding according to gestational age at delivery. // Obstet. Gynecol. 2015. Vol. 125, N 4. P. 808 - 813.

102. Bowman Z.S. et al. Risk factors for unscheduled delivery in patients with placenta accreta. // Am. J. Obstet. Gynecol. 2014. Vol. 210, N 3. P. 241.e1 - 6.

103. Fishman S.G., Chasen S.T. Risk factors for emergent preterm delivery in women with placenta previa and ultrasound findings suspicious for placenta accreta. // J. Perinat. Med. 2011. Vol. 39, N 6. P. 693 - 696.

104. Pri-Paz S. et al. Comparison between emergent and elective delivery in women with placenta accreta. // J. Matern. Fetal. Neonatal Med. 2013. Vol. 26, N 10. P. 1007 - 1011.

105. Warshak C.R. et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. // Obstet. Gynecol. 2010. Vol. 115, N 1. P. 65 - 69.

106. Robinson B.K., Grobman W.A. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. // Obstet. Gynecol. 2010. Vol. 116, N 4. P. 835 - 842.

107. Seoud M.A. et al. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss. // J. Neonatal. Perinatal. Med. 2017. Vol. 10, N 1. P. 9 - 15.

108. Angstmann T. et al. Surgical management of placenta accreta: a cohort series and suggested approach. // Am. J. Obstet. Gynecol. 2010. Vol. 202, N 1. P. 38.e1 - 9.

109. Wade R. et al. Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysis // Health Technol. Assess. (Rockv). 2015. Vol. 19, N 98. P. 1 - 220.

110. Palacios-Jaraquemada J.M. et al. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. // J. Matern. Fetal. Neonatal Med. 2020. P. 1 - 8.

111. Kotsuji F. et al. Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series. // BJOG. 2013. Vol. 120, N 9. P. 1144 - 1149.

112. Шмаков Р.Г., Пирогова М.М., Васильченко О.Н., Чупрынин В.Д. Е.Л.С. Хирургическая тактика при врастании плаценты с различной глубиной инвазии // Акушерство и гинекология. 2020.

113. Shmakov R.G. et al. Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery // J. Matern. Neonatal Med. 2019. Vol. 32, N 12. P. 2042 - 2048.

114. Teixidor Vinas M. et al. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. // Ultrasound Obstet. Gynecol. 2015. Vol. 46, N 3. P. 350 - 355.

115. Alanis M. et al. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. // Fertil. Steril. 2006. Vol. 86, N 5. P. 1514.e3 - 7.

116. Kilicci C. et al. Planned cesarean hysterectomy versus modified form of segmental resection in patients with placenta percreta. // J. Matern. Fetal. Neonatal Med. 2018. Vol. 31, N 22. P. 2935 - 2940.

117. Clausen C., Lonn L., Langhoff-Roos J. Management of placenta percreta: a review of published cases. // Acta Obstet. Gynecol. Scand. 2014. Vol. 93, N 2. P. 138 - 143.

118. Savelieva G.M. et al. [Development and practical implementation of organ preservation surgery in case of placenta accreta in patients with a scar on the uterus]. // Probl. sotsial'noi Gig. Zdr. i Istor. meditsiny. 2019. Vol. 27, N Special Issue. P. 693 - 698.

119. Курцер М.А. Г.А.М. Временная баллонная окклюзия при врастании плаценты // Эндоваскулярная хирургия. 2020. Vol. т. 7 N 2 ст.

120. Shahin A.Y. et al. Bilateral uterine artery ligation plus B-Lynch procedure for atonic postpartum hemorrhage with placenta accreta. // Int. J. Gynaecol. Obstet. 2010. Vol. 108, N 3. P. 187 - 190.

121. Hwu Y.-M. et al. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. // BJOG. 2005. Vol. 112, N 10. P. 1420 - 1423.

122. Баринов С.В., Тирская Ю.И. М.И.В. Способ остановки послеродового кровотечения путем наложения гемостатического наружно-маточного сборочного надплацентарного шва // Российский вестник акушера-гинеколога. 2017.

123. Mei J. et al. Systematic review of uterus-preserving treatment modalities for abnormally invasive placenta. // J. Obstet. Gynaecol. 2015. Vol. 35, N 8. P. 777 - 782.

124. Pan Y. et al. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. // Int. J. Gynaecol. Obstet. 2017. Vol. 137, N 1. P. 45 - 50.

125. Hussein A.M. et al. The role of prophylactic internal iliac artery ligation in abnormally invasive placenta undergoing caesarean hysterectomy: a randomized control trial. // J. Matern. Fetal. Neonatal Med. 2019. Vol. 32, N 20. P. 3386 - 3392.

126. Salim R. et al. Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial. // Obstet. Gynecol. 2015. Vol. 126, N 5. P. 1022 - 1028.

127. Camuzcuoglu A. et al. Surgical management of 58 patients with placenta praevia percreta. // Wien. Klin. Wochenschr. 2016. Vol. 128, N 9 - 10. P. 360 - 366.

128. Kayem G., Keita H. [Management of placenta previa and accreta]. // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2014. Vol. 43, N 10. P. 1142 - 1160.

129. De Mucio B. et al. A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta. // Int. J. Gynaecol. Obstet. 2019. Vol. 147, N 3. P. 281 - 291.

130. Pather S. et al. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. // Aust. N. Z. J. Obstet. Gynaecol. 2014. Vol. 54, N 1. P. 84 - 87.

131. Manzano Nunez R. et al. A meta-analysis of resuscitative endovascular balloon occlusion of the aorta (REBOA) or open aortic cross-clamping by resuscitative thoracotomy in non-compressible torso hemorrhage patients. // World J. Emerg. Surg. 2017. Vol. 12. P. 30.

132. Chen L. et al. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. // BMC Pregnancy Childbirth. 2019. Vol. 19, N 1. P. 30.

133. Chu Q. et al. Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial. // Trials. 2017. Vol. 18, N 1. P. 240.

134. Shahin Y., Pang C.L. Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis. // Eur. Radiol. 2018. Vol. 28, N 7. P. 2713 - 2726.

135. Wei Y. et al. Evaluation of a modified "Triple-P" procedure in women with morbidly adherent placenta after previous caesarean section // Arch. Gynecol. Obstet. 2017. Vol. 296, N 4. P. 737 - 743.

136. Dai Y.M. et al. [Intrauterine balloon tamponade combined with temporary abdominal aortic balloon occlusion in the management of women with placenta accreta spectrum: a randomized controlled trial]. // Zhonghua Fu Chan Ke Za Zhi. 2020. Vol. 55, N 7. P. 450 - 456.

137. Suarez S. et al. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis. // Am. J. Obstet. Gynecol. 2020. Vol. 222, N 4. P. 293.e1 - 293.e52.

138. Wei J. et al. Intrauterine double-balloon tamponade vs gauze packing in the management of placenta previa: A multicentre randomized controlled trial. // Medicine (Baltimore). 2020. Vol. 99, N 7. P. e19221.

139. Tuzovic L., Djelmis J., Ilijic M. Obstetric risk factors associated with placenta previa development: case-control study. // Croat. Med. J. 2003. Vol. 44, N 6. P. 728 - 733.

140. Barinov S. et al. A new approach to fertility-preserving surgery in patients with placenta accreta. // J. Matern. Fetal. Neonatal Med. 2019. Vol. 32, N 9. P. 1449 - 1453.

141. Виницкий А.А., Шмаков Р.Г. Ч.В.Д. Сравнительная оценка эффективности методов хирургического гемостаза при органосохраняющем родоразрешении у пациенток с врастанием плаценты // Акушерство и гинекология. 2017.

142. Kee W.D.N., Khaw K.S., Ng F.F. Prevention of Hypotension during Spinal Anesthesia for Cesarean Delivery // Anesthesiology. 2005. Vol. 103, N 4. P. 744 - 750.

143. Tzeng J.I. et al. Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline // Br. J. Anaesth. 2000. Vol. 85, N 6. P. 865 - 868.

144. Курцер М.А., Бреслав И.Ю., Григорьян А.М. Л.О.А. Опыт использования временной баллонной окклюзии общих подвздошных артерий при органосохраняющих операциях у пациенток с врастанием плаценты // Акушерство и Гинекология. 2013.